September 17, 2020
C-Path Launches Consortium to Accelerate Medical Product Development in Sickle Cell Disease
Related Posts
-
Obtaining and Using TPOXX (Tecovirimat) for the Treatment of Monkeypox -
Workshop: Accelerating Medical Product Development in Kidney Transplantation Through a Public-private Partnership -
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies -
Register Now: DIA 2022 Digital Technology in Clinical Trials Conference -
Register Now | Addressing the Gaps in Clinical Trial Readiness for FSHD